Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved exchanges : Nyse save search
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.03%
H: 2.66%
C: 2.46%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.82%
H: 0.37%
C: 0.17%
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -1.91%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
rare first opioid approval for
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: 6.67%
H: 6.08%
C: 5.03%
fda opioid approval treatment for spray
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.05%
H: 0.85%
C: 0.85%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.19%
H: 0.08%
C: -0.68%
granted approval cancer treatment for
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Published: 2024-04-23 (Crawled : 18:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.69%
H: 0.02%
C: -0.74%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 4.32%
H: 0.0%
C: 0.0%
lutathera fda first approved tumors for novartis therapy
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.13%
H: 1.89%
C: 1.3%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.56%
H: 0.41%
C: -0.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
fda bladder cancer treatment
CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 0.39%
H: 1.73%
C: 1.49%
carvykti approved treatment for
CARFAX Car Listings Approved for GM's IMR Turnkey Program
Published: 2024-04-22 (Crawled : 17:00) - prnewswire.com
SPGI | News | $413.28 0.01% 0.0% 3.1M
|
Commercial Services
|
| O: 0.59%
H: 0.7%
C: 0.47%
approved for program
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.0%
H: 1.92%
C: 1.0%
emblaveo treatment for infections
Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
fda clearance system for ice
Chesapeake Utilities Corporation Gains Approval to Establish Energy Efficiency Programs in Delaware
Published: 2024-04-22 (Crawled : 13:00) - prnewswire.com
CPK | News | $106.89 1.16% 0.0% 150K
|
Utilities
|
| O: -0.01%
H: 0.94%
C: 0.88%
energy approval corporation
Science Based Targets initiative Approves Otis Targets for Reducing Greenhouse Gas Emissions
Published: 2024-04-22 (Crawled : 11:00) - prnewswire.com
OTIS | News | $93.37 -4.21% 0.0% 4.2M
|
Producer Manufacturing
|
| O: -0.22%
H: 1.51%
C: 0.9%
initiative gas for
Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: 0.22%
H: 0.37%
C: 0.1%
health treatment for canada advanced keytruda
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
entyvio fda disease active for therapy
California Water Service Group Moving Forward to Install PFAS Treatment Despite CPUC Dismissal of Request to Track Capital Costs in Pre-Approved Memorandum Account
Published: 2024-04-18 (Crawled : 21:00) - globenewswire.com
CWT | $46.57 0.74% 0.0% 2M
|
Utilities
|
| O: 0.9%
H: 2.19%
C: 2.19%
water california service group treatment
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-18 (Crawled : 18:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
biopharma platform
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
fda biosimilar approval for stelara
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
biopharma platform
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
stelara fda biosimilar approval teva
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: -0.97%
biopharma platform
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.2 -0.07% 0.0% 19K
|
Health Technology
|
| O: 0.19%
H: 0.28%
C: 0.0%
approval for meeting
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.